Literature DB >> 8081762

Analysis of activated T cell infiltrates in rat renal allografts by gamma camera imaging after injection of 123iodine-interleukin 2.

I C Abbs1, J R Pratt, M J Dallman, S H Sacks.   

Abstract

Activated T cells bearing receptors for interleukin 2 (IL-2) play an important role in immunity and in immunopathological processes such as allograft rejection. In order to investigate the presence of activated T cells in lymphocytic infiltrates in transplanted kidneys, we investigated the uptake and retention of radioactivity after an intravenous injection of radioiodinated IL-2 in experimentally transplanted rats. IL-2 was enzyme radiolabelled with 123iodine using a glucose oxidase/lactoperoxidase method and shown to retain specific binding on an IL-2 receptor positive cell line, C58E6. To examine the kinetics of 123iodine-interleukin 2 (123I-IL-2) uptake in vivo, animals that had been transplanted five days previously with allogeneic or syngeneic grafts were injected with 123I-IL-2 and then imaged using an external gamma camera. Radioactivity was measured at time points up to 240 min after intravenous injection of 123I-IL-2. Four groups of animals were examined: allogeneic grafts (n = 7); syngeneic grafts (n = 6); ischaemic native kidneys (n = 5) all following injection with 123I-IL-2; and allogeneic transplants (n = 5) after injection of 123I-lactalbumin, an irrelevant molecule of similar molecular weight to IL-2. The peak radioactivity after injection was measured and the amount of radioactivity retained in the graft at increasing time intervals after injection was expressed as a function of initial peak radioactivity. At four hours after injection of 123I-IL-2, mean retention of activity by rejecting grafts was 77(+/- 2.68)% of peak activity, compared to 45(+/- 6.38)% in syngeneic controls (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8081762     DOI: 10.1016/0966-3274(93)90058-g

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  4 in total

Review 1.  New agents for scintigraphy in rheumatoid arthritis.

Authors:  M H de Bois; E K Pauwels; F C Breedveld
Journal:  Eur J Nucl Med       Date:  1995-11

2.  99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study.

Authors:  M Chianelli; S J Mather; A Grossman; R Sobnak; A Fritzberg; K E Britton; A Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-10       Impact factor: 9.236

3.  Tracking and treating activated T cells.

Authors:  N H Kim; V Nadithe; M Elsayed; O M Merkel
Journal:  J Drug Deliv Sci Technol       Date:  2013-01-01       Impact factor: 3.981

Review 4.  Present status and future trends in molecular imaging of lymphocytes.

Authors:  Chiara Lauri; Michela Varani; Valeria Bentivoglio; Gabriela Capriotti; Alberto Signore
Journal:  Semin Nucl Med       Date:  2022-09-20       Impact factor: 4.802

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.